Sedana Medical Future Growth
Future criteria checks 2/6
Sedana Medical is forecast to grow earnings and revenue by 61.1% and 38.3% per annum respectively. EPS is expected to grow by 46.5% per annum. Return on equity is forecast to be -1.1% in 3 years.
Key information
61.1%
Earnings growth rate
46.5%
EPS growth rate
| Medical Equipment earnings growth | 22.6% |
| Revenue growth rate | 38.3% |
| Future return on equity | -1.1% |
| Analyst coverage | Low |
| Last updated | 02 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 383 | 15 | -22 | 12 | 2 |
| 12/31/2025 | 239 | -41 | -67 | -12 | 2 |
| 12/31/2024 | 183 | -58 | -63 | 98 | 2 |
| 6/30/2024 | 169 | -41 | -176 | 15 | N/A |
| 3/31/2024 | 165 | -23 | -204 | -23 | N/A |
| 12/31/2023 | 154 | -60 | -207 | -38 | N/A |
| 9/30/2023 | 145 | -57 | -224 | -69 | N/A |
| 6/30/2023 | 137 | -58 | -244 | -92 | N/A |
| 3/31/2023 | 127 | -71 | -240 | -95 | N/A |
| 12/31/2022 | 123 | -74 | -253 | -115 | N/A |
| 9/30/2022 | 133 | -54 | -238 | -94 | N/A |
| 6/30/2022 | 135 | -62 | -219 | -82 | N/A |
| 3/31/2022 | 148 | -68 | -177 | -55 | N/A |
| 12/31/2021 | 159 | -58 | -151 | -41 | N/A |
| 9/30/2021 | 159 | -53 | -144 | -37 | N/A |
| 6/30/2021 | 152 | -51 | -124 | -27 | N/A |
| 3/31/2021 | 153 | -38 | -105 | -13 | N/A |
| 12/31/2020 | 142 | -27 | -92 | -8 | N/A |
| 9/30/2020 | 116 | -22 | -85 | -14 | N/A |
| 6/30/2020 | 111 | -14 | -75 | -13 | N/A |
| 3/31/2020 | 88 | -12 | -74 | -16 | N/A |
| 12/31/2019 | 72 | -16 | -61 | -7 | N/A |
| 9/30/2019 | 67 | -13 | -57 | -12 | N/A |
| 6/30/2019 | 63 | -11 | -47 | -7 | N/A |
| 3/31/2019 | 60 | -10 | -38 | -3 | N/A |
| 12/31/2018 | 58 | -7 | -35 | -6 | N/A |
| 9/30/2018 | 53 | -3 | -22 | 9 | N/A |
| 6/30/2018 | 51 | -4 | -34 | -9 | N/A |
| 3/31/2018 | 47 | -3 | N/A | -3 | N/A |
| 12/31/2017 | 42 | -4 | N/A | 0 | N/A |
| 9/30/2017 | 41 | -3 | N/A | -7 | N/A |
| 6/30/2017 | 39 | 0 | N/A | 10 | N/A |
| 3/31/2017 | 36 | 0 | N/A | 0 | N/A |
| 12/31/2016 | 34 | 1 | N/A | 0 | N/A |
| 12/31/2015 | 28 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SEDANS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SEDANS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SEDANS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SEDANS's revenue (38.3% per year) is forecast to grow faster than the UK market (3.7% per year).
High Growth Revenue: SEDANS's revenue (38.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SEDANS is forecast to be unprofitable in 3 years.